Figure 2. The 3-year overall survival for patients with KRAS wild-type vs. KRAS mutations

From

Analysis of KRAS, BRAF and NRAS in Patients with Colorectal Cancer: the First Report of Western Iran

Mehrdad Payandeh, Masoud Sadeghi, Edris Sadeghi, Faezeh Gholami

American Journal of Cancer Prevention. 2015, 3(1), 19-22 doi:10.12691/ajcp-3-1-5